Wiesje M. van der Flier focuses on Dementia, Alzheimer's disease, Pathology, Internal medicine and Atrophy. The Dementia study combines topics in areas such as Psychiatry, Neurology and Cognition. Her Alzheimer's disease research is classified as research in Disease.
Her Pathology research focuses on subjects like Central nervous system disease, which are linked to Stroke and Frontotemporal lobar degeneration. Her Internal medicine research is multidisciplinary, incorporating elements of Gastroenterology and Oncology. Wiesje M. van der Flier has included themes like Voxel-based morphometry, Cardiology, Temporal lobe, Magnetic resonance imaging and Precuneus in her Atrophy study.
Wiesje M. van der Flier focuses on Internal medicine, Dementia, Disease, Cognitive decline and Pathology. Her Internal medicine research integrates issues from Endocrinology, Oncology and Cardiology. Her Dementia study combines topics in areas such as Alzheimer's disease, Neurology, Cognition and Cohort.
When carried out as part of a general Disease research project, her work on Apolipoprotein E and Cognitive impairment is frequently linked to work in In patient, therefore connecting diverse disciplines of study. Wiesje M. van der Flier combines subjects such as Pediatrics and Vascular dementia with her study of Cognitive decline. Wiesje M. van der Flier has researched Pathology in several fields, including Central nervous system disease and Magnetic resonance imaging, Hyperintensity.
Wiesje M. van der Flier mainly focuses on Dementia, Internal medicine, Disease, Cognitive decline and Memory clinic. The various areas that Wiesje M. van der Flier examines in her Dementia study include Cognition, Cognitive impairment, Neuropsychology, Hazard ratio and Cohort. Wiesje M. van der Flier studied Internal medicine and Oncology that intersect with Neurology and Alzheimer's disease.
Her biological study spans a wide range of topics, including Genetics, Gene, Immunology and Gerontology. Her work in Cognitive decline covers topics such as Atrophy which are related to areas like Hyperintensity, Hippocampal atrophy and Endocrinology. Her Cerebrospinal fluid study deals with the bigger picture of Pathology.
Wiesje M. van der Flier mainly investigates Dementia, Internal medicine, Disease, Cognitive decline and Cerebrospinal fluid. Her Dementia research is mostly focused on the topic Memory clinic. Her study in Internal medicine is interdisciplinary in nature, drawing from both Neuropsychological test, Oncology and Cardiology.
As part of the same scientific family, Wiesje M. van der Flier usually focuses on Oncology, concentrating on Alzheimer's disease and intersecting with Stage. In the field of Disease, her study on Apolipoprotein E overlaps with subjects such as Empirical evidence. Her work carried out in the field of Cerebrospinal fluid brings together such families of science as Gastroenterology, Endocrinology and Amyloid.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
CSF biomarkers and incipient Alzheimer disease in patients with mild cognitive impairment.
Niklas Mattsson;Henrik Zetterberg;Oskar Hansson;Niels Andreasen.
Genome-wide meta-analysis identifies new loci and functional pathways influencing Alzheimer's disease risk.
Iris E. Jansen;Jeanne E. Savage;Kyoko Watanabe;Julien Bryois.
Nature Genetics (2019)
Heterogeneity of small vessel disease: a systematic review of MRI and histopathology correlations
Alida A Gouw;Alexandra Seewann;Wiesje M van der Flier;Frederik Barkhof.
Journal of Neurology, Neurosurgery, and Psychiatry (2011)
Prevalence of amyloid PET positivity in dementia syndromes: a meta-analysis.
Rik Ossenkoppele;Willemijn J Jansen;Gil D Rabinovici;Dirk L Knol.
Early-versus late-onset Alzheimer's disease: more than age alone.
Esther L.G.E. Koedam;Vivian Lauffer;Annelies E. van der Vlies;Wiesje M. van der Flier.
Journal of Alzheimer's Disease (2010)
Small Vessel Disease and General Cognitive Function in Nondisabled Elderly The LADIS Study
Wiesje M. van der Flier;Elizabeth C.W. van Straaten;Frederik Barkhof;Ana Verdelho.
Amyloid-β(1–42), Total Tau, and Phosphorylated Tau as Cerebrospinal Fluid Biomarkers for the Diagnosis of Alzheimer Disease
Cees Mulder;Nicolaas A. Verwey;Wiesje M. van der Flier;Femke H. Bouwman.
Clinical Chemistry (2010)
Functional neural network analysis in frontotemporal dementia and Alzheimer's disease using EEG and graph theory
Willem de Haan;Yolande A L Pijnenburg;Rob L M Strijers;Yolande van der Made.
BMC Neuroscience (2009)
Resting-state fMRI changes in Alzheimer's disease and mild cognitive impairment.
Maja A.A. Binnewijzend;Menno M. Schoonheim;Ernesto Sanz-Arigita;Alle Meije Wink.
Neurobiology of Aging (2012)
Brain microbleeds and Alzheimer’s disease: innocent observation or key player?
Charlotte Cordonnier;Wiesje M. van der Flier.
Profile was last updated on December 6th, 2021.
Research.com Ranking is based on data retrieved from the Microsoft Academic Graph (MAG).
The ranking h-index is inferred from publications deemed to belong to the considered discipline.
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: